ISBN 10: 1461292255 / ISBN 13: 9781461292258
Usato / Quantità: 0
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro

Libro

Purtroppo questa copia non è più disponibile. Di seguito ti proponiamo una lista di copie simili.

Descrizione:

Brand New, Unread Copy in Perfect Condition. A+ Customer Service! Summary: Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed. Codice inventario libreria

Su questo libro:

Book ratings provided by Goodreads):
0 valutazione media
(0 valutazioni)

Riassunto: Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo­ gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car­ diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel­ oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol­ ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Condizione libro: New

I migliori risultati di ricerca su AbeBooks

1.

Adam Schneeweiss, Gotthard Schettler
Editore: Springer-Verlag New York Inc., United States (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Paperback Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., United States, 2011. Paperback. Condizione libro: New. Language: English . Brand New Book. Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo- gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car- diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel- oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol- ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed. Softcover reprint of the original 1st ed. 1988. Codice libro della libreria LIB9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 232,64
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

2.

Adam Schneeweiss, Gotthard Schettler
Editore: Springer US 2011-09-21, Boston, MA (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi paperback Quantità: 10
Da
Blackwell's
(Oxford, OX, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer US 2011-09-21, Boston, MA, 2011. paperback. Condizione libro: New. Codice libro della libreria 9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 232,65
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,28
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

3.

Adam Schneeweiss
Editore: Springer-Verlag New York Inc. (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Quantità: > 20
Print on Demand
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., 2011. PAP. Condizione libro: New. New Book. Delivered from our UK warehouse in 3 to 5 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice libro della libreria LQ-9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 231,75
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,86
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Adam Schneeweiss, Gotthard Schettler
Editore: Springer-Verlag New York Inc., United States (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Paperback Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., United States, 2011. Paperback. Condizione libro: New. Language: English . Brand New Book. Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo- gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car- diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel- oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol- ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed. Softcover reprint of the original 1st ed. 1988. Codice libro della libreria LIB9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 242,86
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

Schneeweiss, Adam
Editore: Springer (2016)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Paperback Quantità: 1
Print on Demand
Da
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2016. Paperback. Condizione libro: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Codice libro della libreria ria9781461292258_lsuk

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 247,45
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,24
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Adam Schneeweiss
Editore: Springer-Verlag New York Inc. (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Quantità: > 20
Print on Demand
Da
Pbshop
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., 2011. PAP. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice libro della libreria IQ-9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 248,21
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,39
In U.S.A.
Destinazione, tempi e costi

7.

Adam Schneeweiss
Editore: Springer-Verlag Gmbh Sep 2011 (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Taschenbuch Quantità: 2
Da
Rheinberg-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Sep 2011, 2011. Taschenbuch. Condizione libro: Neu. Neuware - Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed. 386 pp. Englisch. Codice libro della libreria 9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 255,73
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,14
Da: Germania a: U.S.A.
Destinazione, tempi e costi

8.

Adam Schneeweiss
Editore: Springer-Verlag Gmbh Sep 2011 (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Taschenbuch Quantità: 2
Da
Agrios-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Sep 2011, 2011. Taschenbuch. Condizione libro: Neu. Neuware - Cardiovascular drug therapy has markedly progressed in the recent decades. Not only have new drugs been introduced to clinical practice, but new classes of drugs have been developed. While in 1960 the practicing cardiolo gist had a selection of about only ten drugs, in 1987 about 150 drugs are routinely used in cardiovascular diseases. Elderly patients, however, usually do not enjoy the full benefit of this progress. This might be due to lack of knowledge, a conservative approach, or the worldwide tendency not to try new drugs in the elderly. It is now clear that the majority of patients that will be treated in car diovascular clinics will be, in the near future, elderly patients. Even now, elderly patients form about one-third of the patients with cardiovascular diseases. These patients are approached, however, according to criteria devel oped for younger populations. This is despite the fact that elderly patients differ from younger ones in most aspects, including pathology, epidemiol ogy, pathophysiology, diagnostic approach, management, pharmacology, pharmacokinetics, rehabilitation, and supportive treatment. It is the purpose of this book to present to the clinician all drugs with which there is clinical experience in the elderly or which might be potentially useful for the elderly with cardiovascular diseases. The data are presented without the authors taking a position. This should allow the clinicians to make their own selection and individualize treatment, vii viii Preface based on a wide data base. Comparative data are presented only when specific comparative studies were performed. 386 pp. Englisch. Codice libro della libreria 9781461292258

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 255,73
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,14
Da: Germania a: U.S.A.
Destinazione, tempi e costi

9.

ADAM SCHNEEWEISS
Editore: Springer (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Paperback Quantità: 1
Da
Herb Tandree Philosophy Books
(Stroud, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Paperback. Condizione libro: NEW. 9781461292258 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Codice libro della libreria HTANDREE0508803

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 264,16
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 8,76
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

Adam Schneeweiss
Editore: Springer US (2011)
ISBN 10: 1461292255 ISBN 13: 9781461292258
Nuovi Paperback Quantità: 2
Da
Revaluation Books
(Exeter, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer US, 2011. Paperback. Condizione libro: Brand New. reprint edition. 9.25x6.10 inches. In Stock. Codice libro della libreria __1461292255

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 279,61
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,57
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Vedi altre 3 copie di questo libro

Vedi tutti i risultati per questo libro